Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc (NQ: ALLK )

0.8950 -0.0150 (-1.65%)
Streaming Delayed Price Updated: 9:30 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Allakos Inc

< Previous 1 2 3 4 5 Next >
Mid-Afternoon Market Update: CalAmp Drops After Q3 Results; Red Cat Holdings Shares Surge
Toward the end of trading Wednesday, the Dow traded up 0.51% to 35,674.84 while the NASDAQ rose 0.53% to 15,422.40. The S&P also rose, gaining 0.60% to 4,677.06. The U.... 
Via Benzinga
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV... 
Via Benzinga
Why Allakos Shares Are Plummeting Today
Allakos Inc (NASDAQ: ALLK) is trading significantly lower Wednesday after the company announced ENIGMA 2 and KRYPTOS studies did not achieve statistical significance on the... 
Via Benzinga
ALLK Stock Alert: Why Is Allakos Absolutely Plunging Today?
Allakos' recent study results have sent ALLK stock straight to the bottom. Here's what investors should know right now. 
Via InvestorPlace
Expert Ratings For Allakos
Allakos (NASDAQ:ALLK) has observed the following analyst ratings within the... 
Via Benzinga
Stocks Extend Rally as VIX Moves Lower
The market rebound is carrying onto Wednesday's trading, with the Dow Jones Industrial Average erasing this morning's losses to eye a 161-point pop. Both the S&P 500 Index and Nasdaq Composite (are not... 
Via Talk Markets
Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.41% to 35,637.05 while the NASDAQ rose 0.80% to 15,463.85. The S&P also rose, gaining 0.67% to 4,680.45. The U.S. has the... 
Via Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United... 
Via Benzinga
Mid-Morning Market Update: Markets Edge Higher; CarMax Profit Tops Estimates
Following the market opening Wednesday, the Dow traded up 0.11% to 35,530.68 while the NASDAQ rose 0.02% to 15,344.33. The S&P also rose, gaining 0.13% to 4,655.40. The U.S.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE: 
Via Benzinga
Allakos' Shares Nosedive After Lirentelimab Studies Fail To Achieve Statistical Significance On Symptomatic Endpoints
Allakos Inc (NASDAQ: ALLK) reported data from ENIGMA 2 Phase 3 study of lirentelimab in eosinophilic gastritis (EG) or eosinophilic duodenitis (EoD) and KRYPTOS Phase 2/3... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 54.72% to $2.29 during Wednesday's pre-market session. The company's market cap stands at $... 
Via Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Allakos's Lirentelimab Flunks Late-Stage Studies In Patients With... 
Via Benzinga
3 Biotech Stocks With Huge Catalysts Incoming
These drugmakers have big events that should occur before the end of 2021. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE: 
Via Benzinga
3 Biotech Stocks That Could Double Soon
Wall Street analysts following these drugmakers think they can produce big gains in a short time frame. 
Via The Motley Fool
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,... 
Via Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.